National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)
NCT05326620 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2025-06-06
Summary
PRO-RCC is a nationwide long-term cohort for the collection of real-world clinical data, patient reported outcome measures (PROMs) and patient reported experience measures (PREMs) that provides an infrastructure for observational research and (randomized) interventional studies with the TwiCs (Trial within cohorts) design.
Conditions
- Renal Cancer
- Renal Cell Carcinoma
- Renal Cell Cancer Metastatic
Sponsors & Collaborators
-
Comprehensive Cancer Centre The Netherlands
collaborator OTHER - collaborator INDUSTRY
- collaborator INDUSTRY
- collaborator INDUSTRY
- collaborator INDUSTRY
-
PROspective Renal Cancer Cohort Foundation
lead OTHER
Principal Investigators
-
Adriaan Bins, MD, PhD · Amsterdam UMC
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-19
- Primary Completion
- 2030-01-31
- Completion
- 2030-01-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Biomarkers of Angiogenesis for Response to Therapeutic Combination in Advanced or Metastatic Kidney Cancer
NCT05285579 ·Status: UNKNOWN
-
Prospective Validation of Circulating Tumor Cells & Circulating Endothelial Cells as Biomarkers in Renal Cancer
NCT02499458 ·Status: COMPLETED
-
The ONCOCAMP Study
NCT06270602 ·Status: RECRUITING
-
Optical Biopsy to Improve the Diagnosis of Kidney Cancer
NCT02073110 ·Status: UNKNOWN
-
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
NCT00026884 ·Status: RECRUITING
-
Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC
NCT02143492 ·Status: COMPLETED
-
Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer
NCT02664883 ·Status: ACTIVE_NOT_RECRUITING
-
Urine Proteome of Surgical Patients and Healthy Volunteers
NCT01538823 ·Status: COMPLETED
-
Genetic Evaluation of Renal Cell Carcinoma; Predicting Biomarkers for Renal Cell Carcinoma
NCT03414827 ·Status: RECRUITING
-
KidneyCare Cohort Study (KCC-S)
NCT06898632 ·Status: COMPLETED
-
Tertiary Lymphoid Structures Related Genes Predicting Prognosis in Clear Cell Renal Cell Carcinoma: a Retrospective Cohort Study
NCT06883565 ·Status: COMPLETED
-
Cohort Study of Pancreatic Cancer Risk
NCT04247503 ·Status: ACTIVE_NOT_RECRUITING
-
Adrenal Vein Sampling as a Tool to Identify Biomarkers That Aid the Diagnosis of Adrenocortical Carcinoma
NCT05660889 ·Status: UNKNOWN
-
A Genotype-Phenotype Urothelial Cancer Registry
NCT00902590 ·Status: ACTIVE_NOT_RECRUITING
-
Analysis of Prostate Cancer Short-Term Cultures Using Molecular Cytogenetic Methods
NCT00022919 ·Status: COMPLETED
-
Mechanisms of Somatic Mutation and Tumor Initiation in Pre-malignant Kidney Tubule Cells
NCT06194669 ·Status: RECRUITING
-
Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.
NCT01398306 ·Status: COMPLETED
-
Delving Into Participation Trends in Renal Cell Carcinoma Studies
NCT06093568 ·Status: NOT_YET_RECRUITING
-
Towards an Easy-to-use Adrenal Cancer/Tumor Identity Card
NCT02672020 ·Status: COMPLETED ·Phase: NA
-
The Belgian Molecular Profiling Program of Metastatic Cancer for Clinical Decision and Treatment Assignment
NCT03873103 ·Status: UNKNOWN
-
PRO-VISION: Patient Reported Outcomes-Based Monitoring of VEGF-Inhibitor Side Effects in ONcology
NCT05592665 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Tumor Molecular Profiling in Patients With Prostate Cancer
NCT05573789 ·Status: COMPLETED
-
Evaluation of HPGD and SCLO2A1 Expression in Clear Cell Renal Cell Carcinoma Patients
NCT06778538 ·Status: COMPLETED
-
Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer
NCT00806650 ·Status: COMPLETED
-
Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing
NCT02090530 ·Status: RECRUITING